Stratec - Stock

Stratec P/E 2024

Stratec P/E

29.61

Ticker

SBS.DE

ISIN

DE000STRA555

WKN

STRA55

As of Jun 11, 2024, Stratec's P/E ratio was 29.61, a -44.85% change from the 53.69 P/E ratio recorded in the previous year.

The Stratec P/E history

Stratec Aktienanalyse

What does Stratec do?

The company Stratec SE is a German company operating in the medical technology industry. It was founded in 1984 and has since become a leading provider of automation solutions and diagnostic instruments. Stratec's business model is based on the development and production of devices and systems used in medical diagnostics. The company focuses in particular on the areas of immunology, clinical chemistry, and hematology. Stratec also offers innovative solutions in microscopy and cell analysis. In the "automation solutions" division, Stratec develops systems for the automation of laboratory processes. These are mainly used in clinical diagnostics to accelerate and simplify workflow. Examples include sample identification systems, pipetting robots, and analysis devices. In the "in vitro diagnostics" division, Stratec offers products for determining blood values. This includes devices for determining glucose, cholesterol, and hemoglobin levels, as well as devices for infection diagnostics and tumor and allergy diagnostics. Another division of Stratec is "microscopy." The company manufactures automated microscope systems, primarily used in biomedical research to analyze cells and tissues. In the "cell analysis" division, Stratec offers innovative methods for analyzing cells, such as cell growth and vitality determination. Stratec always focuses on tailoring the design of its products to the needs of its customers. High flexibility in device development and manufacturing is therefore an important factor in the company's success. In addition to device development and production, Stratec also provides services related to its products. These include installation, maintenance, and on-site repair of devices for customers. Stratec SE operates internationally and has branches in Europe, Asia, and America. The company employs over 1,000 people worldwide. Overall, Stratec SE is a successful and renowned provider of medical devices and systems for automating laboratory processes. With its diverse product portfolio and high flexibility in customer support, Stratec has earned a leading position in the industry. Stratec ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Stratec's P/E Ratio

The Price to Earnings (P/E) Ratio of Stratec is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Stratec's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Stratec is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Stratec’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Stratec Stock

What is the price-to-earnings ratio of Stratec?

The price-earnings ratio of Stratec is currently 29.61.

How has the price-earnings ratio of Stratec changed compared to last year?

The price-to-earnings ratio of Stratec has increased by -44.85% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Stratec high compared to other companies?

Yes, the price-to-earnings ratio of Stratec is high compared to other companies.

How does an increase in the price-earnings ratio of Stratec affect the company?

An increase in the price-earnings ratio of Stratec would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Stratec affect the company?

A decrease in the price-earnings ratio of Stratec would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Stratec?

Some factors that influence the price-earnings ratio of Stratec are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Stratec pay?

Over the past 12 months, Stratec paid a dividend of 0.97 EUR . This corresponds to a dividend yield of about 2.05 %. For the coming 12 months, Stratec is expected to pay a dividend of 1.05 EUR.

What is the dividend yield of Stratec?

The current dividend yield of Stratec is 2.05 %.

When does Stratec pay dividends?

Stratec pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of Stratec?

Stratec paid dividends every year for the past 0 years.

What is the dividend of Stratec?

For the upcoming 12 months, dividends amounting to 1.05 EUR are expected. This corresponds to a dividend yield of 2.22 %.

In which sector is Stratec located?

Stratec is assigned to the 'Health' sector.

Wann musste ich die Aktien von Stratec kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Stratec from 5/22/2024 amounting to 0.55 EUR, you needed to have the stock in your portfolio before the ex-date on 5/20/2024.

When did Stratec pay the last dividend?

The last dividend was paid out on 5/22/2024.

What was the dividend of Stratec in the year 2023?

In the year 2023, Stratec distributed 0.95 EUR as dividends.

In which currency does Stratec pay out the dividend?

The dividends of Stratec are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Stratec stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Stratec

Our stock analysis for Stratec Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Stratec Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.